Multidisciplinary Dissection of Renal and Metabolic Effects of Glyfozines on Elderly Patients: From Molecular Aspects to Clinical Indications

The project aims to study the impact of SGLT2i therapy on clinical and biochemical aspects. in elderly. The project will combine different types of data, such as clinical and biological information, and will use advanced Bayesian statistical methods to understand the relationship between risk factors and patient outcomes following treatment with SGLT2 inhibitors.

NCT Number	NCT07119424
Lead Sponsor	Chiara Lanzani
Conditions	Elderly Patients (>65 Years), Diabetes (DM), Heart Disease, Renal Diseases, Internal Disease
Enrollment	300 participants
Start Date	2025-02-14
Primary Completion	2026-11 (estimated)
Study Completion	2027-02 (estimated)
Updated on ClinicalTrials.gov	2025-08-13